Antonio Paul on Blame Game in Transplantation: HLA vs Microbes
Antonio Paul, Head of ACTIMoS- Advanced Center for Transplant Immunology and Molecular Science, shared on LinkedIn:
”Blame Game in Transplantation: HLA vs Microbes
What if HLA antibodies are not always about HLA?
For decades, we’ve taught that anti-HLA antibodies arise from the usual suspects:
- Prior transplants
- Blood transfusions
- Pregnancy
But many patients develop de novo anti-HLA antibodies without any classic sensitization history.
Growing evidence suggests another culprit: Infections.
What’s happening?
Microbes can trigger HLA antibodies through several mechanisms:
- Molecular mimicry – Microbial antigens may resemble HLA epitopes, leading to cross-reactive antibodies.
- Innate immune “danger signals” – Toll-like receptor activation can break immune tolerance and promote rejection.
- Bystander B-cell activation – Cytokine surges during infection can awaken dormant HLA-reactive memory B cells.
- Polyclonal immune activation – Broad antibody expansion may occur after infections or vaccinations.
Clinical evidence shows that infections often precede:
– Increased panel reactive antibodies (PRA)
– Emergence of donor-specific antibodies (DSA)
– Higher rejection risk
– Poorer graft survival
Rethinking an old assumption
Not all HLA antibodies are born from mismatched HLA.
Some may be born from mismatched microbes.
Transplant success may depend not only on how well donors and recipients are matched, but also on which microbes the immune system remembers.”

Stay updated with Hemostasis Today.
-
Nov 8, 2026, 12:22Marc Carrier: Advancing Catheter-Related Thrombosis Prevention Through Factor XI Inhibition
-
Nov 8, 2026, 11:56Why Genetic Predisposition Does Not Always Lead to Thrombosis – Stork Genetics
-
Nov 8, 2026, 11:45Sher-Lu Pai: Investigating Intracardiac Thrombosis and Its Management in Liver Transplantation
-
Nov 8, 2026, 11:25Mehmet Cilingiroglu: Navigating Anticoagulation Choices in Acute Coronary Syndrome PCI
-
Nov 8, 2026, 07:16Gilberto de lima Lopes Junior: The Cardiovascular Consequences of Cancer in Younger Patients
-
Nov 8, 2026, 06:51Haney Mallemat: Key Principles and Pitfalls of LVAD Emergencies
-
Nov 8, 2026, 06:31Maria Omer: Clinical Recognition and Management of Cavernous Sinus Thrombosis
-
Nov 8, 2026, 06:16Natasha Jolakoski: University of New Mexico Hospital Promotes PGY-2 Thrombosis and Hemostasis Management Pharmacy Residency
-
Nov 8, 2026, 05:47Safaa Hilal: POCUS in the Evaluation of Perioperative Troponin Elevation